Tuesday, May 26, 2026
Today's Edition

EveryNews

Stories that matter, signal over noise

Politics

New HIV cases in Ukraine have decreased — but mortality and regional risks persist

Over three years (2022–2025) registered HIV cases fell from 12,212 to 8,024. We explain what lies behind the figures and why this does not mean the epidemic has been overcome.

Tetiana Suchkova-Ladik

By Tetiana Suchkova-Ladik

February 25, 2026 · 2 min read

New HIV cases in Ukraine have decreased — but mortality and regional risks persist
Пацієнт в лікарні (ілюстративне фото: freepik)

What happened and why it matters

Official statistics from the Public Health Center show a decline in registered HIV cases in Ukraine from 12,212 in 2022 to 8,024 in 2025. At first glance — noticeable progress. However, at the same time in 2025, 1,094 people died from diseases related to HIV/AIDS. These data are important now because they shape the reality of prevention and treatment programs and international funding.

"In 2025, 1,094 people died in Ukraine from causes related to HIV infection and AIDS."

— Public Health Center of the Ministry of Health of Ukraine (in response to a request from LIGA.net)

Data by year and registration nuances

Official figures by year: 2022 — 12,212, 2023 — 11,658, 2024 — 10,038, 2025 — 8,024. At the same time, the Center clarifies that children whose HIV diagnosis is still being confirmed are not included in the statistics. This means some cases may remain outside official records until diagnostic confirmation is completed.

Regional hotspots to watch

As of January 1, 2026, the highest prevalence rates (per 100,000 population) were recorded in Dnipropetrovsk (901.2), Odesa (773.4), Mykolaiv (694.2) regions and in Kyiv (527.2). By incidence rate in 2025, the leaders were Dnipropetrovsk (46.4), Odesa (45.6) and Mykolaiv (34.0) regions. This means the need for testing, therapy and support programs is concentrated in these regions.

Why cases fell — several explanations

Experts point to several simultaneous reasons: the introduction and scaling up of antiretroviral therapy (ART) and prevention programs are having an effect; but factors related to the war also play a role — population migration, limited access to medical services in combat zones, and a temporary reduction in testing and case registration. In other words, part of the decline may be a real epidemiological success, and part an artifact of changes in the healthcare system.

Associated risks: tuberculosis and meningitis

The Ministry of Health has also reported that Ukraine records about 50 cases of tuberculosis of the nervous system per year. Tuberculosis, especially when combined with HIV, increases the risk of severe disease and death. Therefore control of both diseases must proceed in parallel — from diagnosis to access to treatment.

What this means for the state and communities

This is not the time for complacency: testing programs must be preserved and expanded, uninterrupted access to ART ensured, monitoring updated in regions with high rates, and the diagnosis of children who are currently not included in the registry completed. It is also a signal to international partners: statistics are variable, and investments in health systems remain critical infrastructure for our security.

Systematic work by healthcare workers, volunteers and programs is producing results, but the war complicates epidemic control. Now it is up to politicians and donors — declarations must be turned into resources for targeted programs in the regions with the highest burden.

Related

Latest

Business

EU Against Google: Why the Latest Fine Could Change More Than Previous Ones

# European Regulators Target Google Again — This Time Over Digital Markets Act Violations. What's Behind the Accusations and Why It Matters Beyond the Corporation European regulators have renewed their scrutiny of Google, this time focusing on alleged violations of the Digital Markets Act. The charges underscore Brussels' increasingly aggressive stance on big tech monopolies and what officials say are anticompetitive practices. The accusations center on how Google leverages its dominance across multiple digital services — from search to advertising to mobile platforms — to disadvantage competitors. Regulators claim the company is using its market power in ways that stifle innovation and limit consumer choice. The case carries significance far beyond Google itself. It signals how the EU is attempting to enforce its landmark Digital Markets Act, legislation designed to curb the gatekeeping power of tech giants. A potential penalty could set precedent for how other large technology companies face similar scrutiny. For consumers and smaller tech firms, the outcome could reshape the digital landscape by creating more room for competition. For Google, fines and operational restrictions could fundamentally alter its business model in Europe, the world's most stringent regulatory market. The case also reflects a broader geopolitical divide, with the EU pursuing a regulatory approach that contrasts sharply with the lighter-touch oversight favored in the United States.

May 26, 2026